Playground Global — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Amber Bio is a biotechnology company developing a novel RNA writing platform capable of multi-kilobase gene edits that can treat multiple mutations across patients with a single product.
AI & Machine LearningBiotechDeep Tech
Jacob Borrajo, PhD(Founder and CEO)Basem Al-Shayeb(Founder)Jacob Borrajo(Founder)inJacob Borrajo Basem Al-Shayeb(Founder)
Co-investorsAndreessen HorowitzHummingbird VenturesPillar VC
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
Tim Craven(CEO)inToby Passioura(Founder)inGlen McIntyre(Founder)Timothy Craven(Founder)
BoardCOREY GOODMAN(Director)in
PartnerBen Kim· led
Board seatMatt Hershenson· per SEC Form D
Co-investorsBEVCCivilization Ventures Management, LlcMRL Ventures FundvenBio PartnersAxial VCvenBio Global Strategic
Atomic.ai combines machine learning and RNA biology to discover and develop RNA-based drugs.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Raphael Townshend(Founder & CEO)inManjunath Ramarao(Chief Scientific Officer)inStephan Eismann(Founding Scientist, Head of Machine Learning)inEsta Kor(Head of Business Operations)inBrent Townshend(Head of ML Data Generation)in
Co-investorsAIX VenturesAME Cloud VenturesGreylock PartnersModi VenturesNot Boring CapitalStartX+3 more
Phasecraft develops quantum computing systems and software by combining quantum information theory, materials science, and engineering to advance practical quantum advantage.
AI & Machine LearningDeep TechQuantum Computing
Prof. Ashley Montanaro(Co-Founder & CEO)inProf. Toby Cubitt(Co-Founder, CTO & CSciO)inProf. John Morton(Co-Founder & Director)inAshley Montanaro(Founder)John Morton(Founder)Toby Cubitt(Founder)
Co-investorsAlbionVCEpisode1LocalGlobeUCL Technology FundLondon Co-Investment FundNovo Holdings+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Amber Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



























